Categories: CancerHealthcareNews

Dermatologist Recommended Acnomel Offers Safe Alternative To Treat Acne

Following New Report That Found Cancer-Causing Ingredient In Popular Acne Treatments

EDISON, NJ / ACCESSWIRE / March 15, 2024 / Consumers are seeking safer alternatives to meet their skincare needs following a new report that uncovered the possible presence of cancer-causing benzene in popular acne treatments containing benzoyl peroxide1. Addressing this growing concern, Adult Acnomel® tinted acne cream is gaining attention as a trusted solution with over 70 years of proven efficacy in treating both adult and teen acne.

Acnomel is formulated with two effective ingredients: resorcinol 2% and sulfur 8%. This unique composition not only clears up acne but also prevents future pimple formation. Another one of Acnomel’s standout features is its tinted formula, which conceals blemishes while actively working to treat acne. This dual-action approach has garnered attention from dermatologists, national media and users across social media platforms like, TikTok, where users praise its remarkable results.

Regarding the power of sulfur to treat acne, New York City-based dermatologist Libby Rhee, DO, stated2, “Sulfur contains natural anti-inflammatory, antibacterial, and keratolytic properties, thus addressing the three main components causing acne and breakouts. In other words, this single ingredient can improve redness, combat the Propionibacterium acnes bacterium in the skin, and help the skin shed and reproduce itself more efficiently, which decreases pore clogging.”

Acnomel offers consumers a safe and cost-effective solution, priced at just $13 per tube on Amazon and also available at Rite Aid stores nationwide.

“We recognize the significance of offering safe and reliable skincare products,” stated Khalil Daya, General Manager of Acnomel’s parent company, DSE Healthcare Solutions. “Acnomel has remained a safe and effective acne treatment for decades, and we’re excited to introduce it to a new generation.”

For media inquiries, sample requests, or further information about Acnomel, please contact Alexis Valenti at avalenti@bridgeandvali.com or 312-613-4822.

  1. https://www.valisure.com/valisure-newsroom/valisure-detects-benzene-in-benzoyl-peroxide
  2. https://www.wellandgood.com/sulfur-good-for-acne-treatment/

About DSE Healthcare Solutions

DSE Healthcare Solutions, LLC (DSE) is a privately held consumer healthcare company. We manufacture and market a portfolio of brands primarily within the vitamin, digestive health and skincare categories. Our collection of legacy, challenger brands set us apart. We proudly rejuvenate enduring, no-frills health and wellness brands to introduce them to new generations. Discover our nostalgic brand stories and see how authenticity, a focus on quality ingredients, and a commitment to our values still meets contemporary needs. When it comes to everyday health and wellness, we believe simpler is better – and always will.

SOURCE: DSE Healthcare Solutions, LLC

View the original press release on accesswire.com

Staff

Recent Posts

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

16 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

16 hours ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

16 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

16 hours ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

16 hours ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…

16 hours ago